Four patients with hereditary glucose phosphate isomerase (GPI) deficiency and their parents have been studied by means of various enzymatic, immunologic, electrophoretic, and stability methods. The four defective mutants enzymes (identified here as "GPI Barcelona," "GPI Utrecht," "GPI Nijmegen," and "GPI Kortrijk") were antigenically identical with normal enzyme as judged by double immunodiffusion and microcomplement fixation tests. Immunologic specific activity (i.e., the ratio of enzyme activity to antigen concentration) was slightly lowered for three variants (between 60 and 75% of normal). The various methods used allowed us to establish that all of the patients were heterozygous for two different mutated alleles inherited from each parent. O n e of them was a silent allele which did not seem t o code for any enzymatic cross-reacting material; the other mutated gene coded for a structurally modified glucose phosphate isomerase subunit.
In two parents heterozygous for a structurally modified gene, onlv two enzymatic forms were detected, even in the young cells
--
syAhesizing \ctively proteins such as granulocytes: one was the normal homodimer. and the other c o r r e s~o n d e d to the heterodimer "normal subunit-mutant subunit"; ihe mutant homodimer was not detected. The assumption that, in these heterozygotes, the mutant subunit dimerized more easily with a normal subunit than with another mutant subunit could be proposed. In contrast, the three expected enzyme forms were detected in the leukocytes from a woman heterozygous for G P I Nijmegen. From these results the defect in activity observed in the patients could be explained in the following way: 50% of the defect was due to the inheritance of a silent gene. The decrease below 50% of the residual activity in red cells was due to the molecular instability of the mutant enzyme associated in three cases (GPI Barcelona, G P I Utrecht, and G P I Kortrijk) with the decreased immunologic specific activity.
Speculation at least 25 new cases have beendescibed.
Glucose phosphate isomerase is a dimeric molecule (7); its structural gene is autosomal, located on the chromosome 19 (14, 17) . A single genetic form of glucose phosphate isomerase is synthesized in all the cells of the organism (2, 7, 16) . Consequently, the structural mutation of this enzyme will be expressed in all the tissues. Since the niutations usually result in increased lability of the enzyme, however, the defect in activity will be maximum in the aged and anucleated cells, such as the red cells (1) . Thus, the pathologic consequences of the enzyme deficiency will involve mainly the red blood cells, leading to chronic hemolysis. Sometimes, however, glucose phosphate isomerase deficiency can be responsible for some metabolic disturbances in various tissues, as demonstrated by Van Biervliet et nl. (19) in the case of the patient with "GPI Utrecht." The aim of the present work was to elucidate the genetic and molecular mechanisms of the defect in glucose phosphate isomerase activity detected in different families.
MATERIALS AND METHODS
All the substrates, coenzymes, and auxiliary enzymes were purchased from Boehringer-Mannheim o r Sigma CC. Tetrazolium salt MTT and phenazine methosulfate were furnished by Sigma CC. Ampholines of pH range 9-11 were furnished by LKB. Isoelectrofocusing was performed in a ISCO model 212 column, or in a Biorad model 150 A electrophoresis cell. Agarose was from 1'Industrie biologique franqaise," acrylamide and bisacrylamide from Eastman Kodak, and starch for gel electrophoresis from Connaught. Enzymatic reactions were measured at 30" in Zeiss PMQ I1 or Gilford 2400 spectrophotometers. The reagents used in the microcomplement fixation tests came from I'Institut Pasteur in Paris. BLOOD 
SAMPLES
In spite of the relatively high frequency of the mutations which ~l~~d was anticoagulated with acid citrate dextrose (formula are responsible for a silent G P I structural gene, G P I deficiency A) in plastic tubes. Leukocytes, platelets, and red cells were due t o the inheritance of two Silent genes has never been de-separated by methods previously reported (10) . scribed. It can be s~e c u l a t e d that the homoweous state of such a mutation, which would lead to null enzymeactivity in all the tissues, could be lethal. A s in most cases of genetic disorders due ENZYME ASSAYS to silent genes, the nature of the mutation involved is unknown. A deletion, a polar mutation, a structural mutation leading to a
The standard assay of glucose phosphate isomerase activity highly labile product, o r a cis-dominant regulator mutation are Was performed t x~k w a r d (fructose-6-~hos~hate + glucose-6-the different genetic hypotheses which could be put forward. phosphate), according to the method of Beutler ( 6 ) . Hemoglobin concentration was measured by the cyanmethemoglobin method, and protein concentration by the Lowry method (13). The congenital defect in glucose phosphate isomerase activity The results were expressed in international units per g hemoglo-(EC. 5.3.1.9) represents the third most frequent enzymopathy bin or per mg protein.
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KAHN ELECTROPHORESIS AND ELECTROFOCUSING STUDIES
Starch gel electrophoretic study of the mutant glucose phosphate isomerase variants was performed according to the method of Detter et al. (7) , in Tris-citrate buffer, pH 8. Isoelectrofocusing was performed either in sucrose gradient or in columns (5 x 120 mm) of 5% (w/v) acrylamide containing 1 % ampholine, pH 9-1 1, and 0.2 IU/ml yeast glucose-6-phosphate dehydrogenase (9) . The anodic tank, at the top of the columns, contained 1% (vlv) acetic acid, and the cathodic tank, at the bottom, 4 % (v/v) ethanolamine. Glucose phosphate isomerase activity was specifically revealed on the gels as described elsewhere (10) .
SEARCH FOR ANTIGENIC DIFFERENCES BETWEEN WILD AND MUTANT ENZYMES
Normal glucose phosphate isomerase was totally purified from human leukocytes as previously reported (5) . Two different lots of monospecific anti-glucose phosphate isomerase sera were grown in rabbits; their titers were, respectively. 120 and 250 IU precipitated enzyme per ml antiserum (5) .
The double immunodiffusion experiments were performed according to the method of Ouchterlony (15); these compared the immunoprecipitate lines obtained with normal and mutant leukocyte enzymes.
Microcomplement fixation tests were performed according to the method of Levine and Van Vunakis (1 1), and slightly modified in that the total reaction mixture was 1.4 ml instead of 7 ml. In these experiments the antigen source was either leukocyte crude extracts or purified preparations (5) . Lyophilized guinea pig serum (as complement source) was diluted 1,320 times and antiserum (first lot) was diluted 18,000 times. A range of enzyme dilutions having total enzyme activity from 2 x 10-"0 4 0 x IU was used.
IMMUNOLOGIC TITRATIONS
Glucose phosphate isomerase-related antigen concentration was measured by electroimmunodiffusion, according to a method we have previously described (5) (Fig. 1) . The ratio of the enzyme activity to the antigen concentration (i.e., the "immunologic specific activity") was determined from these experiments by plotting the enzyme activity versus the surfaces of the i m m~n~~; e c i~i t a -t e immunol~gic specific activity is proportional to the s l o~e of the straight line obtained. and was kxpressed as a percentage of the G l u e found for the enzyme from fresh leukocyte extracts studied in the same experiment ( Fig. 1 ).
HEAT STABILITY STUDY
Stability to heat of the enzyme activity from normal and mutant enzymes was appraised at 48' in 100 mM Tris-HCI buffer, pH 8 , containing 1 mM E-aminocaproic acid, 1 mM diisopropylfluorophosphate, 1 mM EDTA, and 2 mg/ml bovine albumin (10) .
PATIENTS
Our studies involved the families in which the variants GPI Barcelona, GPI Utrecht, GPI Nijmegen, and GPI Kortrijk have been discovered. Clinical observations and biochemical characterizations have been described in previous papers (l0,20-22), or will be published elsewhere (18) . In order to make the account of the results easier, we will designate the patients and their families by the name of the variant.
RESULTS
SEARCH FOR ALTERED ANTIGENICITY OF MUTANT GLUCOSE PHOSPHATE ISOMERASE VARIANTS
The double immunodiffusion tests showed patterns of immunologic complete identity between normal enzyme and all the four variants. This result was similar with either antiserum lot. The microcomplement fixation curve of GPI Nijmegen was identical with that of normal enzyme. With GPI Barcelona, GPI Utrecht, and GPI Kortrijk the maximum amount of complement fixed was normal (about 80%). The curves, however, were slightly shifted to the left, this maximum fixation being reached with about 7.5 x IU Barcelona or Utrecht variants, 6.3 IU GPI Kortrijk and 10 x IU normal enzymes (Fig. 2) . The same results were obtained with either lot of antiserum, whether leukocyte crude extracts or purified preparations were used.
ENZYMATIC AND IMMUNOLOGIC TITRATIONS
The results of the enzymatic and immunologic titrations of glucose phosphate isomerase from the blood cells of the patients and their parents are summarized in Tables 1, 2 The enzyme activity in leukocytes and platelets is expressed in international units per mg proteins. In the red cells it is expressed in international units per g hemoglobin. Enzyme-related antigen concentration is expressed in percentage of the normal values. The ratio of the enzyme activity to the antigen concentration is expressed in percentage of the value found for a normal, freshly prepared, leukocyte extract studied in the same experiment. For explanation of units of measure, see footnote 1 of Table 1 .
Families o f Patients with Variants Barcelona, Utrecht, and Nijtnegen. In the patient with GPI Barcelona, immunologic specific activity o t the defective enzyme was about 75% of normal (Fig. 1) ; residual enzyme activity was about 15% of normal in the leukocytes, platelets, and red cells. In the patient with GPI Utrecht, immunologic specific activity was reduced to about 75% of normal, as well (Fig. 1) . The defect in activity was 23% of normal in the leukocytes, 30% in the platelets, and 17%
in the red cells. In the patient with G P I Nijmegen, immunologic specific activity was normal. Enzyme activity was about 50% of normal in the leukocytes and 27% in the red cells.
In all the three families the patients' fathers had both glucose phosphate isomerase activity and antigen concentration decreased about by half in the leukocytes and the erythrocytes. Consequently, immunologic specific activity was normal in all of these cases. In the mothers of the Utrecht and Nijmegen patients, enzyme activity was nearly normal in the leukocytes, the defect in activity reaching 55% and 59% of normal in the red 1126 KAHN ET AL. blood cells. Enzyme activity ranged from 62-65% of normal in all the blood cells of the mother of the Barcelona patient.
Immunologic specific activity of glucose phosphate isomerase was nearly normal in all the blood cells of these women. Family of Patient with GPI Kortrijk. In the patient, immunologic specific activity of the defective enzyme was decreased to 6 5 % of normal in the leukocytes. The defect, in activity as well as in enzyme-related antigen, was apparently more severe in the leukocytes (11% and 17% of normal, respectively) than in the red cells (36% and 48%).
In the father, glucose phosphate isomerase activity and enzyme-related antigen concentration were slightly decreased in the leukocytes and reduced by half in the red cells. These values were decreased in parallel by about half in the red cells. These values were decreased in parallel by about half in the leukocytes as well as in the red cells from the mother.
ELECTROPHORETIC AND ELECTROFOCUSING DATA (FIG. 3)
Electrophoretic and electrofocusing patterns of glucose phosphate isomerase were normal in the family of the Utrecht patient.
In the patient with GPI Barcelona, a single enzyme form was detected, the isoelectric point of which was 9.55. The mother's blood cells exhibited two forms, one having normal electrophoretic migration and normal isoelectric point (PI: 9.22), the other having a migration intermediate between that of normal enzyme and that of the defective enzyme from the propositus. Glucose phosphate isomerase from the father's blood cells had normal electrophoretic mobility and normal isoelectric point.
The patient with GPI Nijmegen showed a single anodic active band (PI: 8.95) in all of the blood cells. The mother's leukocytes contained three active forms: one was identical with that of the patient cells, the second had intermediate electrophoretic mobility, and the third had normal electrophoretic migration and isoelectric point. The father exhibited a single enzyme form, with normal mobility in both the white blood cells and the red cells (Figs. 4 and 5) .
By starch gel electrophoresis both the red cells and the leukocytes from the patient with GPI Kortrijk showed a single fast migrating active band (Fig. 6 ). Isoelectrofocusing tests, however, were unable to detect any modification of isoelectric point of this defective enzyme. Electrophoretic mobility was normal in the mother. In the father, two active bands were detected. One, predominant in the white blood cells and less important in the red cells, had a migration intermediate between that of enzyme from the patient and a control subject; the other band had normal migration.
HEAT STABILITY STUDIES
Stability to heat of the defective enzyme from the four patients was decreased in the leukocytes, as well as in the red cells. In the leukocytes, the curves log V/VO = f(heating time) were biphasic 
DESIGNATION
in the mothers of the patients with the variants Barcelona, Utrecht, and Nijmegen, and in the father of the fourth patient (with GPI Kortrijk); these curves were normal in the other parents (Fig. 7) .
The results of the double immunodiffusion and microcomplement fixation analyses seem to indicate that, with respect to the different lots of antiwild enzyme used, the four defective enzymes tested herein and normal glucose phosphate isomerase were antigenically identical.
The complete identity found by immunodiffusion, indeed, signified that the antiserum used recognized the same antigenic determinants on the mutant and normal enzymes (8, 12) . In microcomplement fixation tests, the variants Barcelona, Utrecht, and Kortrijk fixed as much complement as normal enzyme. The fixation curves plotted versus the enzyme activity of the dilutions, however, were shifted to the left. This finding signified only that the same antigen amount, which corresponds to the maximum fixation, had an enzyme activity lower for the mutant enzymes than for normal glucose phosphate isomerase. By contrast, according to Levine and Van Vunakis ( l l ) , the reduced number of antigenic determinants recognized by the antiserum would result in a vertical shift of the curve and a qualitative alteration of these antigenic determinants would result in a shift to the right. The fixation curve obtained with GPI Nijmegen was totally identical with that obtained with normal enzyme.
This antigenic identity between normal and mutant glucose phosphate isomerase enables the accurate measurement of en- zyme-related antigen concentration and immunologic specific activity of the mutant enzyme variants with respect to normal enzyme. These immunologic titrations gave, mainly, two pieces of information. ( I ) All three fathers of the patients with the variants Barcelona, Utrecht, and Nijmegen, together with the mother of the patient with GPI Kortrijk, exhibited a parallel reduction of 5 0 % of both enzyme activity and antigen concentration in the leukocytes and the red cells. Consequently, the most likely hypothesis was that these subjects were heterozygous for a silent gene that did not code for anv cross-reacting material.
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( 2 ) Immunologic specific activity of three variants was slightly (but reproductibly) decreased: to 75% of normal for the variants Barcelona and Utrecht and to 60-65% of normal for GPI Kortrijk. Such a decrease of the ratio of the enzyme activity t o the antigen concentration explained a part of the observed defect in glucose phosphate isomerase activity.
The electrophoretic and clcctrofocusing data obtained in the patients and their parents allowed the genetic determinism of the enzyme activity deficiency found in the patients with GPI Barcelona, GPI Nijmegen, and GPI Kortrijk to be specified. These three variants showed abnormal electrophoretic mobilities: fast for the variants Barcelona and Kortrijk and slow for the variant Nijmegen. No abnormal active band was detected in the fathers of the patients with the variants Barcelona and Nijmegen and in the mother of the patient with GPI Kortrijk, supporting the concept of the silent allele in these subjects. The mother of the patient Barcelona and the father of the patient Kortrijk exhibited an additional fast migrating active band predominant in the leukocytes and minor in the red cells; this additional band with an intermediate migration probably corresponded to the Fig. 7 . H e a t stability a t 48' of glucose phosphate isomerase (GPI) f r o m t h e patient with GPI Utrecht a n d his family. Leukocyte extracts were diluted in a 1 0 0 m M Tris-HCI buffer, p H 8, containing 1 m M P-mercaptoethanol, 1 m M EDTA, 1 m M e-aminocaproic acid, a n d 1 rnM diisopropylfluorophosphate.
h e t e r o d i m e r " n o r m a l s u b u n i t -m u t a n t s u b u n i t . " T h e mutant homodimer w a s not d e t e c t e d , even in t h e l e u k o c y t e s , w h i c h are y o u n g c e l l s a c t i v e l y s y n t h e s i z i n g p r o t e i n s . The o n l y i n s t a b i l i t y o f the mutant homodimer did not seem t o be sufficient to explain i t s absence i n t h e l e u k o c y t e s o f t h e h e t e r o z y g o t e s , s i n c e t h e p a t i e n t s ' l e u k o c y t e s s h o w e d a n o t i c e a b l e amount of this form.
T h e h y p o t h e s i s that the d i m e r i z a t i o n of the m u t a n t s u b u n i t w i t h a n o r m a l subunit is favored w i t h respect t o the f o r m a t i o n of the m u t a n t h o m o d i m e r can be put f o r w a r d . By c o n t r a s t , in t h e mother of the patient w i t h t h e variant Nijmegen, t h e three forms (i.e., normal homodimer, heterodimer, and m u t a n t homodimer) were e a s i l y distinguished by e i t h e r s t a r c h g e l e l e c t r o p h o r e s i s or In the case o f GPI U t r e c h t , w h o s e e l e c t r o p h o r e t i c m o b i l i t y was n o r m a l , the t h e r m a l s t a b i l i t y t e s t s w i t h the l e u k o c y t e enzymes a l l o w e d c o n f i r m a t i o n o f the f a c t s t h a t t h e f a t h e r w a s h e t e r o z y g o u s f o r a s i l e n t gene a n d t h e m o t h e r f o r a s t r u c t u r a l l y a b n o r m a l enzyme; t h e heat i n a c t i v a t i o n c u r v e of t h e f a t h e r ' s l e u k o c y t e enzyme was t o t a l l y i d e n t i c a l w i t h t h a t o f n o r m a l glucose p h o s p h a t e isomerase. In t h e mother, t w o forms c o u l d be c l e a r l y d i s t i n g u i s h e d a c c o r d i n g t o t h e i r stability: o n e w a s as u n s t a b l e as GPI Utrecht and t h e o t h e r as stable as n o r m a l enzyme (Fig. 7) .
From t h e r e s u l t s r e p o r t e d above, t h e d e f e c t i n e n z y m e a c t i v i t y in the patients' red c e l l s could be e x p l a i n e d in the f o l l o w i n g w a y :
all o f t h e p a t i e n t s were h e t e r o z y g o u s f o r t w o d i f f e r e n t m u t a t e d a l l e l e s i n h e r i t e d f r o m each p a r e n t . One o f t h e m w a s a s i l e n t gene, a n d the o t h e r a s t r u c t u r a l l y m o d i f i e d gene. F i f t y p e r c e n t o f t h e d e f e c t i n a c t i v i t y w a s due t o the i n h e r i t a n c e o f t h e s i l e n t g e n e . In t h e p a t i e n t w i t h GPI N i j m e g e n t h e decrease b e l o w 50% of r e s i d u a l a c t i v i t y was o n l y due t o i n s t a b i l i t y o f t h e m u t a n t enzyme. I n t h e o t h e r cases t h e d e c r e a s e b e l o w 50% o f r e s i d u a l a c t i v i t y w a s b o t h e x p l a i n e d by decreased i m m u n o l o g i c s p e c i f i c a c t i v i t y and m o l e c u l a r i n s t a b i l i t y o f the m u t a n t v a r i a n t s .
The f a c t t h a t t h e d e f e c t i n a c t i v i t y a s s o c i a t e d w i t h GPI Kort r i j k w a s a p p a r e n t l y more pronounced in the l e u k o c y t e s t h a n in t h e red c e l l s s h o u l d be i n t e r p r e t e d i n f u n c t i o n o f t h e h i g h r e t i c ul o c y t e count (as h i g h as 70%) f o u n d i n t h e p a t i e n t : if i t i s p o s s i b l e t o express t h e r e s i d u a l l e u k o c y t e e n z y m e a c t i v i t y as a p e r c e n t a g e of n o r m a l , t h i s is n o t c o r r e c t f o r red cell g l u c o s e p h o s p h a t e i s o m e r a s e s i n c e t h e r e d c e l l s f r o m t h i s p a t i e n t a r e f a r younger t h a n t h o s e f r o m a n o r m a l c o n t r o l w i t h a n o r m a l r e t i c ul o c y t e count.
I t s h o u l d be n o t e d t h a t i n a l l of t h e cases s t u d i e d in t h i s paper a s i n g l e m o l e c u l a r f o r m exists i n the p a t i e n t s , since t h e s i l e n t genes i n h e r i t e d from one of t h e p a r e n t s did not seem to code for any p r o t e i n recognized a n t i g e n i c a l l y o r e n z y m a t i c a l l y as g l u c o s e p h o s p h a t e i s o m e r a s e . C o n s e q u e n t l y , i t seems t o be correct to c h a r a c t e r i z e t h e s e v a r i a n t s by a d i s t i n c t d e s i g n a t i o n , i n c o n t r a s t w i t h the cases in w h i c h t h e defect r e s u l t s from t h e inheritance of t w o d i f f e r e n t s t r u c t u r a l l y m o d i f i e d enzymes.
In conclusion, the combination of various i m m u n o l o g i c , elect r o p h o r e t i c , and s t a b i l i t y s t u d i e s a l l o w s t h e a c c u r a t e a n a l y s i s of t h e g e n e t i c d e t e r m i n i s m and t h e m o l e c u l a r m e c h a n i s m o f the congenital defects in glucose phosphate isomerase activity. 
Summary
This study reports a serologic method for the measurement of kidney-derived antigens in the urine of healthy children and of children with renal diseases. Two hundred twenty patients were studied. Four groups were recognized:group A , patients with no evidence of renal disease; group B , patients with past history of active urinary tract infection; group C , patients with active urinary tract infection; group D , patients with other renal diseases.
Urinary renal antigen concentration was tested by the complement fivation method, in which titers of antigens in the urine were compared with a standard human renal antigen extract. The distribution of renal antigen concentrations in group C differed significantly ( P ( x 2 ) less than 0.001) from the other three groups. About 85% of patients ingroups A , B , and D had levels below 0.6 mglml, whereas ingroup C only 53% of patients had similar concentrations. After factoring the results by the urinary concentration of creatinine, 85% of patients in group C had antigen levels above 0.6 mg/ml as opposed to 24%, 44%, and 27% ingroups A , B, and D , respectively. The results of the study are consistent with the assumption that the rate of discharge of renal antigenic material in the urine is accelerated in certain renal diseases.
Speculation
Titers of renal antigen in urines of patients with urinary tract infection may differentiate parenchymal disease from lower tract disease. Monitoring of the pattern of renal antigen excretion may provide a n index for optimal duration of antibacterial therapy in pyelonephritis.
Investigators have long been trying to find satisfactory methods for the assessment of the activity of renal diseases and the
